Viewing Study NCT06121557


Ignite Creation Date: 2025-12-24 @ 6:59 PM
Ignite Modification Date: 2026-05-26 @ 11:12 AM
Study NCT ID: NCT06121557
Status: RECRUITING
Last Update Posted: 2023-11-08
First Post: 2023-10-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HER2-Negative View
None Lymph Node View
None Lymphocytes View
None Adoptive Cell Therapy View
None Camrelizumab View
None Chemotherapy View
None Antibody-Drug Conjugate View
None Poly(ADP-ribose) Polymerase Inhibitor View